These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 34521903)

  • 1. SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar.
    Seedat S; Chemaitelly H; Ayoub HH; Makhoul M; Mumtaz GR; Al Kanaani Z; Al Khal A; Al Kuwari E; Butt AA; Coyle P; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Bertollini R; Abu-Raddad LJ
    Sci Rep; 2021 Sep; 11(1):18182. PubMed ID: 34521903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.
    Seon JY; Jeon WH; Bae SC; Eun BL; Choung JT; Oh IH
    J Korean Med Sci; 2021 May; 36(20):e148. PubMed ID: 34032033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period, United States.
    Griffin I; King J; Lyons BC; Singleton AL; Deng X; Bruce BB; Griffin PM
    Emerg Infect Dis; 2024 Jun; 30(6):1144-1153. PubMed ID: 38781926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic.
    Abu-Raddad LJ; Chemaitelly H; Ayoub HH; Al Kanaani Z; Al Khal A; Al Kuwari E; Butt AA; Coyle P; Jeremijenko A; Kaleeckal AH; Latif AN; Owen RC; Rahim HFA; Al Abdulla SA; Al Kuwari MG; Kandy MC; Saeb H; Ahmed SNN; Al Romaihi HE; Bansal D; Dalton L; Al-Thani MH; Bertollini R
    Sci Rep; 2021 Mar; 11(1):6233. PubMed ID: 33737535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: Spatial analysis of hospital case-fatality rate in France.
    Souris M; Gonzalez JP
    PLoS One; 2020; 15(12):e0243606. PubMed ID: 33320895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar.
    Tang P; Hasan MR; Chemaitelly H; Yassine HM; Benslimane FM; Al Khatib HA; AlMukdad S; Coyle P; Ayoub HH; Al Kanaani Z; Al Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Nasrallah GK; Al Kuwari MG; Al Romaihi HE; Butt AA; Al-Thani MH; Al Khal A; Bertollini R; Abu-Raddad LJ
    Nat Med; 2021 Dec; 27(12):2136-2143. PubMed ID: 34728831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above.
    Syed MA; Al Nuaimi AS; A/Qotba HA; Nasrallah GK; Althani AA; Yassine HM; Zainel AA; Khudadad H; Marji T; Veettil ST; Al-Jighefee HT; Younes S; Shurrab F; Al-Sadeq DW; AlFehaidi AAS; Yfakhroo AI; AlMesaifri MA; Al Mujalli H; Al Abdulla SA; Al Kuwari MG; Azad FM; Al Malki BAM; Abdulmalik MA
    BMC Infect Dis; 2021 Jul; 21(1):645. PubMed ID: 34225657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of SARS-CoV-2-Positive Youths Tested in Emergency Departments: The Global PERN-COVID-19 Study.
    Funk AL; Florin TA; Kuppermann N; Tancredi DJ; Xie J; Kim K; Neuman MI; Ambroggio L; Plint AC; Mintegi S; Klassen TP; Salvadori MI; Malley R; Payne DC; Simon NJ; Yock-Corrales A; Nebhrajani JR; Chaudhari PP; Breslin KA; Finkelstein Y; Campos C; Bergmann KR; Bhatt M; Ahmad FA; Gardiner MA; Avva UR; Shah NP; Sartori LF; Sabhaney VJ; Caperell K; Navanandan N; Borland ML; Morris CR; Gangoiti I; Pavlicich V; Kannikeswaran N; Lunoe MM; Rino PB; Kam AJ; Cherry JC; Rogers AJ; Chong SL; Palumbo L; Angelats CM; Morrison AK; Kwok MY; Becker SM; Dixon AC; Poonai N; Eckerle M; Wassem M; Dalziel SR; Freedman SB;
    JAMA Netw Open; 2022 Jan; 5(1):e2142322. PubMed ID: 35015063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
    Butt AA; Dargham SR; Chemaitelly H; Al Khal A; Tang P; Hasan MR; Coyle PV; Thomas AG; Borham AM; Concepcion EG; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    JAMA Intern Med; 2022 Feb; 182(2):197-205. PubMed ID: 34935861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.
    Taylor CA; Patel K; Pham H; Whitaker M; Anglin O; Kambhampati AK; Milucky J; Chai SJ; Kirley PD; Alden NB; Armistead I; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Teno K; Weigel A; Monroe ML; Ryan PA; Henderson J; Nunez VT; Bye E; Lynfield R; Poblete M; Smelser C; Barney GR; Spina NL; Bennett NM; Popham K; Billing LM; Shiltz E; Abdullah N; Sutton M; Schaffner W; Talbot HK; Ortega J; Price A; Garg S; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1513-1519. PubMed ID: 34710076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection.
    Wu J; Zhang J; Sun X; Wang L; Xu Y; Zhang Y; Liu X; Dong C
    Diabetes Obes Metab; 2020 Oct; 22(10):1907-1914. PubMed ID: 32496012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France.
    Dao TL; Hoang VT; Nguyen NN; Delerce J; Chaudet H; Levasseur A; Lagier JC; Raoult D; Colson P; Gautret P
    Clin Microbiol Infect; 2021 Oct; 27(10):1516.e1-1516.e6. PubMed ID: 34044152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in severity, mortality, and virus genome among a Spanish cohort of patients hospitalized with SARS-CoV-2.
    Aznar-Gimeno R; Paño-Pardo JR; Esteban LM; Labata-Lezaun G; Esquillor-Rodrigo MJ; Lanas A; Abadía-Gallego D; Diez-Fuertes F; Tellería-Orriols C; Del-Hoyo-Alonso R; Serrano MT
    Sci Rep; 2021 Sep; 11(1):18844. PubMed ID: 34552127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.
    Deng LS; Yuan J; Ding L; Chen YL; Zhao CH; Chen GQ; Li XH; Li XH; Luo WT; Lan JF; Tan GY; Tang SH; Xia JY; Liu X
    Infect Dis Poverty; 2020 Dec; 9(1):163. PubMed ID: 33261654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 in Children in the United States: Intensive Care Admissions, Estimated Total Infected, and Projected Numbers of Severe Pediatric Cases in 2020.
    Pathak EB; Salemi JL; Sobers N; Menard J; Hambleton IR
    J Public Health Manag Pract; 2020; 26(4):325-333. PubMed ID: 32282440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February-18 April 2020.
    Al Kuwari HM; Abdul Rahim HF; Abu-Raddad LJ; Abou-Samra AB; Al Kanaani Z; Al Khal A; Al Kuwari E; Al Marri S; Al Masalmani M; Al Romaihi HE; Al Thani MH; Coyle PV; Latif AN; Owen R; Bertollini R; Butt AA
    BMJ Open; 2020 Oct; 10(10):e040428. PubMed ID: 33033033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Cross-Reactive Immunity to COVID-19 Infection in Individuals With Laboratory-Confirmed MERS-CoV Infection: A National Retrospective Cohort Study From Saudi Arabia.
    Khan AA; Alahmari AA; Almuzaini Y; Alamri F; Alsofayan YM; Aburas A; Al-Muhsen S; Van Kerkhove M; Yezli S; Ciottone GR; Assiri AM; Jokhdar HA
    Front Immunol; 2021; 12():727989. PubMed ID: 34603300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.